Call us at (888) 828-2206. We'll help answer any questions you may have.
Fedratinib is a selective oral JAK2 inhibitor that is FDA approved for use in myelofibrosis. It is being studied for use in other indications as well.
December 09, 2023
You can give us a call at (888) 828-2206 or create your account to add this treatment to your list of favorites. We'll send you alerts when this treatment is updated.
Create My Account